Related Experiment Video

Updated: Jul 11, 2026

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
09:55

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

Published on: December 20, 2021

Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226

Chun-Jen Chen1, Mei-Hua Hsu, Li-Jiau Huang

  • 1Graduate Institute of Pharmaceutical Chemistry, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40421, Taiwan, ROC.

Biochemical Pharmacology
|September 21, 2007
PubMed

Insights

The anticancer drug candidate YC-1 selectively targets lung cancer cells (NCI-H226) by halting cell cycle progression and inducing apoptosis. It also inhibits metastasis, suggesting potential as a lung cancer chemotherapy agent.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Ongoing search for novel anticancer drug candidates.
  • YC-1 (1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole) identified as a selective cytotoxic agent against NCI-H226 lung cancer cells.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying YC-1's selective toxicity in NCI-H226 cells.
  • To evaluate YC-1's potential as a lung cancer chemotherapy agent.

Main Methods:

  • In vitro anticancer screening using NCI-H226 cell line.
  • Cell cycle analysis (G0/G1 phase arrest).
  • Western blot analysis for cell cycle regulatory proteins (cyclin D1, CDK2, cdc25A, p16, p21, p53).
  • Mitochondrial-dependent apoptosis assay.
  • Matrix metalloproteinase (MMP-2 and MMP-9) activity assay.

Main Results:

  • YC-1 inhibited NCI-H226 cell growth in a time- and concentration-dependent manner.
  • YC-1 suppressed cyclin D1, CDK2, and cdc25A protein levels, while up-regulating p16, p21, and p53.
  • Cells accumulated in the G0/G1 phase, and apoptosis was induced via the mitochondrial pathway.
  • YC-1 inhibited MMP-2 and MMP-9 activity, reducing tumor cell metastasis.

Conclusions:

  • YC-1 exhibits a multi-faceted mechanism of action, including cell cycle arrest, apoptosis induction, and inhibition of metastasis.
  • YC-1 demonstrates significant potential as a novel chemotherapy agent for lung cancer treatment.

More Related Videos

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...